Avatar Medical

Avatar Medical specializes in developing software tools for orthopaedic and craniofacial implantation planning. Their primary focus is on orthopaedic/craniofacial implantation planning software, specifically solutions for shoulder positioning, such as tools like *brAIn Shoulder Positioning* and *Avatar Medical Software V1*. These digital platforms help surgeons with preoperative planning and surgical navigation, ensuring precise and tailored surgical approaches.

Avatar Medical is based in the United States, which means their devices fall under the regulatory jurisdiction of the FDA (U.S. Food and Drug Administration). Since their products are authorised for use in the U.S., they must comply with FDA requirements, including classification as Class II devices, and are listed in the FDA’s 510(k) and UDI registries to demonstrate compliance and traceability.

Avatar Medical’s devices are listed in the FDA’s 510(k) Premarket Notification and UDI (Unique Device Identification) registries—two key databases that track medical devices authorised for sale in the U.S. The 510(k) registry confirms that each device has undergone a premarket submission process to demonstrate safety and effectiveness compared to a predicate device. The UDI registry ensures traceability and transparency in the supply chain, allowing healthcare providers, regulators, and patients to verify device details, such as batch numbers and manufacturing dates.

Avatar Medical’s devices are classified as Class II under FDA regulations. This classification indicates that they pose a moderate risk to patients and require special controls—such as performance standards, post-market surveillance, or labeling requirements—to ensure safety and effectiveness. While Class II devices undergo stricter oversight than Class I (lower-risk) devices, they do not require the rigorous clinical trials typically associated with Class III (high-risk) devices. The classification helps regulators balance innovation with patient safety.